AbbVie says FDA approves Skyrizi for ulcerative colitis

Read Time:6 Second

AbbVie said that the heavily-advertised drug was now approved for four conditions across different so-called “immune-mediated” inflammatory diseases.

About Post Author

Happy

0 %

Sad

0 %

Excited

0 %

Sleepy

0 %

Angry

0 %

Surprise

0 %

The package-delivery giant said reduced demand for priority services and higher operating costs weighed on results.

Elliott Hill will replace John Donahoe as chief executive next month, following months of struggles for the athletic-wear giant.

It’s that time again: Investors will see option contracts tied to more than $5 trillion in tradeable stocks expire on...

Mortgage rates inched up even though the Federal Reserve cut interest rates. Experts explain why this is a short-lived phenomenon.

Republican presidential nominee Donald Trump on Wednesday promised to cap interest rates for credit cards, but a veteran analyst predicts...

Fed Chair Jerome Powell emphasized a policy “recalibration.” Investors like the sound of it.